Proteinases as virulence factors in Leishmania spp. infection in mammals

Parasites and Vectors

Volumn 5, Issue 1, 2012, Pages

  Silva Almeida, Mariana ^a   Pereira, Bernardo Acácio Santini ^a   Ribeiro Guimarães, Michelle Lopes ^a   Alves, Carlos Roberto ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Leishmania spp.; Leishmaniasis; Lesion; Protease; Proteinase

Indexed keywords

CYSTEINE PROTEINASE; METALLOPROTEINASE; SERINE PROTEINASE; VIRULENCE FACTOR;

ENZYME ACTIVITY; IMMUNOMODULATION; LEISHMANIA; LEISHMANIASIS; MAMMAL; NONHUMAN; PARASITE SURVIVAL; PARASITE VIRULENCE; PROTEIN FUNCTION; REVIEW;

ANIMALS; HUMANS; LEISHMANIA; LEISHMANIASIS; MAMMALS; PEPTIDE HYDROLASES; VIRULENCE FACTORS;

ANIMALIA; MAMMALIA;

EID: 84864765264     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-5-160     Document Type: Review

References (101)

1. Leishmaniasis. Allison MJ, The Cambridge World History of Human Disease Cambridge University Press, Cambridge Histories Online, Kiple KF, 1993 Vol 1
2. Leishmaniasis, an emerging imported infection: report of 20 cases from Australia. Stark D, van Hal S, Lee R, Marriott D, Harkness J, J Travel Med 2008 15 5 351 354 10.1111/j.1708-8305.2008.00223.x 19006509
3. The current status of zoonotic leishmaniases and approaches to disease control. Gramiccia M, Gradoni L, Int J Parasitol 2005 35 1169 1180 10.1016/j.ijpara.2005.07.001 16162348 (Pubitemid 41395178)
4. Leishmaniasis: current situation and new perspectives. Desjeux P, Comp Immunol Microbiol Infect Dis 2004 27 5 305 318 10.1016/j.cimid.2004.03.004 15225981 (Pubitemid 38842803)
5. Leishmaniasis, an emerging infection in travelers. Pavlia A, Maltezoub HC, Inter J Infect Dis 2010 14 12 1032 e1039 10.1016/j.ijid.2010.06.019
6. New insights into the developmental biology and transmission mechanisms of Leishmania. Bates PA, Rogers ME, Curr Mol Med 2004 4 6 601 609 10.2174/1566524043360285 15357211 (Pubitemid 39172366)
7. Tegumentary and visceral leishmaniases in Brazil: emerging anthropozoonosis and possibilities for their control. Marzochi MC, Marzochi KB, Cad Saude Publica 1994 10 suppl 2 359 375 15042226
8. Cutaneous Leishmaniasis. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, Lancet Infect Dis 2007 7 9 581 596 10.1016/S1473- 3099(07)70209-8 17714672 (Pubitemid 47277438)
9. Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63. McGwire BS, Chang KP, Engman DM, Infect Immun 2003 71 2 1008 1010 10.1128/IAI.71.2.1008-1010.2003 12540585 (Pubitemid 36150799)
10. Leishmania mexicana: binding of promastigotes to type I collagen. Lira R, Rosales-Encina JL, Argüello C, Exp Parasitol 1997 85 2 149 157 10.1006/expr.1996.4127 9030665 (Pubitemid 27247975)
11. Characterization of the cellular immune response in American cutaneous leishmaniasis. Castes M, Agnellia A, Verde O, Rondán AJ, Clin Immunol Immunopathol 1983 27 2 176 186 10.1016/0090-1229(83)90068-5 6409480 (Pubitemid 13127254)
12. Immunopathology of American cutaneous leishmaniasis. Pirmez C, Mem Inst Oswaldo Cruz 1992 87 suppl 5 105 109 1343880
13. Mucosal leishmaniasis: epidemiological and clinical aspects. Lessa MM, Lessa HA, Castro TW, Oliveira A, Scherifer A, Machado P, Carvalho EM, Braz J Otorhinolaryngol 2007 73 6 843 847 18278231
14. Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome. Sinha S, Fernández G, Kapila R, Lambert WC, Schwartz RA, Int J Dermatol 2008 47 12 1263 1270 10.1111/j.1365-4632.2008.03804. x 19126013
15. Leishmania infection and virulence. Matlashewski G, Med Microbiol Immunol 2001 190 37 42 11770107 (Pubitemid 33079355)
16. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Proudfoot L, O'Donnell CA, Liew FY, Eur J Immunol 1995 25 3 745 750 10.1002/eji.1830250318 7705404
17. Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. Zufferey R, Allen S, Barron T, Sullivan DR, Denny PW, Almeida IC, Smith DF, Turco SJ, Ferguson MA, Beverley SM, J Biol Chem 2003 278 45 44708 44718 10.1074/jbc.M308063200 12944391 (Pubitemid 37377228)
18. Characterization of Leishmania (Viannia) braziliensis membrane microdomains, and their role in macrophage infectivity. Yoneyama KA, Tanaka AK, Silveira TG, Takahashi HK, Straus AH, J Lipid Res 2006 47 10 2171 2178 10.1194/jlr.M600285-JLR200 16861743 (Pubitemid 44936127)
19. Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors. Svárovská A, Ant TH, Seblová V, Jecná L, Beverley SM, Volf P, PLoS Negl Trop Dis. 2010 4 1 580 10.1371/journal.pntd.0000580 20084096
20. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts. Gaur U, Showalter M, Hickerson S, Dalvi R, Turco SJ, Wilson ME, Beverley SM, Exp Parasitol. 2009 122 3 182 91 10.1016/j.exppara.2009.03.014 19328787
21. The Leishmania receptor for macrophages is a lipid-containing glycoconjugate. Handman E, Goding JW, EMBO J 1985 4 2 329 336 4018028
22. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Späth GF, Epstein L, Leader B, Singer SM, Avila HA, Turco SJ, Beverley SM, Proc Natl Acad Sci USA 2000 97 16 9258 9263 10.1073/pnas.160257897 10908670 (Pubitemid 30626706)
23. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Späth GF, Garraway LA, Turco SJ, Beverley SM, Proc Natl Acad Sci USA 2003 100 16 9536 9541 10.1073/pnas. 1530604100 12869694 (Pubitemid 37033963)
24. Leishmania mexicana: participation of NF-kappaB in the differential production of IL-12 in dendritic cells and monocytes induced by lipophosphoglycan (LPG). Argueta-Donohué J, Carrillo N, Valdés-Reyes L, Zentella A, Aguirre-García M, Becker I, Gutiérrez-Kobeh L, Exp Parasitol 2008 120 1 1 9 10.1016/j.exppara.2008. 04.002 18508052
25. Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Liu D, Kebaier C, Pakpour N, Capul AA, Beverley SM, Scott P, Uzonna JE, Infect Immun 2009 77 8 3272 3283 10.1128/IAI.01447-08 19487470
26. Molecular cloning and characterization of a novel repeat-containing Leishmania major gene, ppg1, that encodes a membrane-associated form of proteophosphoglycan with a putative glycosylphosphatidylinositol anchor. Ilg T, Montgomery J, Stierhof YD, Handman E, J Biol Chem 1999 274 44 31410 31420 10.1074/jbc.274.44.31410 10531342 (Pubitemid 29508502)
27. Proteophosphoglycans of Leishmania. Ilg T, Parasitol Today 2000 16 11 489 497 10.1016/S0169-4758(00)01791-9 11063860
28. Proteophosphoglycan secreted by Leishmania mexicana amastigotes causes vacuole formation in macrophages. Peters C, Stierhof YD, Ilg T, Infect Immun 1997 65 2 783 786 9009342 (Pubitemid 27053251)
29. Secreted proteophosphoglycan of Leishmania mexicana amastigotes activates complement by triggering the mannan binding lectin pathway. Peters C, Kawakami M, Kaul M, Ilg T, Overath P, Aebischer T, Eur J Immunol 1997 27 10 2666 2672 10.1002/eji.1830271028 9368624 (Pubitemid 27453858)
30. Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein. Jardim A, Funk V, Caprioli RM, Olafson RW, Biochem J 1995 305 307 313 7826346
31. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients. Carvalho LP, Passos S, Dutra WO, Soto M, Alonso C, Gollob KJ, Carvalho EM, Ribeiro de Jesus A, Scand J Immunol 2005 61 4 337 342 10.1111/j.1365-3083.2005.01581.x 15853916 (Pubitemid 40637838)
32. Classification of peptidases. Barrett AJ, Methods Enzymol 1994 244 1 15 7845199
33. Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5. Denise H, Poot J, Jiménez M, Ambit A, Herrmann DC, Vermeulen AN, Coombs GH, Mottram JC, BMC Mol Biol 2006 13 7 42
34. Cysteine peptidases as virulence factors of Leishmania. Mottram JC, Coombs GH, Alexander J, Curr Opin Microbiol 2004 7 4 375 381 10.1016/j.mib.2004.06.010 15358255 (Pubitemid 39091122)
35. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. Alexander J, Coombs GH, Mottram JC, J Immunol 1998 161 12 6794 6801 9862710 (Pubitemid 28562223)
36. Expression of multiple CPB genes encoding cysteine proteases is required for Leishmania mexicana virulence in vivo. Denise H, McNeil K, Brooks DR, Alexander J, Coombs GH, Mottram JC, Infect Immun 2003 71 6 3190 3195 10.1128/IAI.71.6.3190-3195.2003 12761098 (Pubitemid 36637542)
37. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, Scott P, J Immunol 2003 171 7 3711 3717 14500670 (Pubitemid 37254576)
38. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Weinheber N, Wolfram M, Harbecke D, Aebischer T, Eur J Immunol 1998 28 8 2467 2477 10.1002/(SICI)1521-4141(199808) 28:08<2467::AID-IMMU2467>3.0.CO;2-1 9710224 (Pubitemid 28362721)
39. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Bennett CL, Misslitz A, Colledge L, Aebischer T, Blackburn CC, Eur J Immunol 2001 31 3 876 883 10.1002/1521-4141(200103)31:3<876::AID- IMMU876>3.0.CO;2-I 11241293 (Pubitemid 32237124)
40. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R, J Immunol 2004 173 5 3297 3304 15322192 (Pubitemid 39142038)
41. Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions. Abu-Dayyeh I, Hassani K, Westra ER, Mottram JC, Olivier M, Infect Immun 2010 78 6 2438 2445 10.1128/IAI.00812-09 20368344
42. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. Pollock KG, McNeil KS, Mottram JC, Lyons RE, Brewer JM, Scott P, Coombs GH, Alexander J, J Immunol 2003 170 4 1746 1753 12574338 (Pubitemid 36197389)
43. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. De Souza Leao S, Lang T, Prina E, Hellio R, Antoine JC, J Cell Sci 1995 108 3219 3231 7593283
44. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis. Alves CR, Benévolo-De-Andrade TC, Alves JL, Pirmez C, Parasite Immunol 2004 26 3 127 135 10.1111/j.0141-9838.2004.00691.x 15279623 (Pubitemid 39070684)
45. In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection. Pereira BA, Silva FS, Rebello KM, Marín-Villa M, Traub-Cseko YM, Andrade TC, Bertho ÁL, Caffarena ER, Alves CR, BMC Immunol 2011 12 44 10.1186/1471-2172-12-44 21824434
46. Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 response. Bryson K, Besteiro S, McGachy HA, Coombs GH, Mottram JC, Alexander J, Infect Immun 2009 77 7 2971 2978 10.1128/IAI.00558-08 19433541
47. The C-terminal extension of Leishmania pifanoi amastigote-specific cysteine proteinase Lpcys2: a putative function in macrophage infection. Marín-Villa M, Vargas-Inchaustegui DA, Chaves SP, Tempone AJ, Dutra JM, Soares MJ, Ueda-Nakamura T, Mendonça SC, Rossi-Bergmann B, Soong L, Traub-Csekö YM, Mol Biochem Parasitol 2008 162 1 52 59 10.1016/j. molbiopara.2008.07.003 18694784
48. Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses. da Costa Pinheiro PH, de Souza Dias S, Eulálio KD, Mendonça IL, Katz S, Barbiéri CL, Infect Immun 2005 73 6 3787 3789 10.1128/IAI.73.6.3787-3789.2005 15908413 (Pubitemid 40745928)
49. Analysis of the roles of cysteine proteinases of Leishmania mexicana in the host-parasite interaction. Frame MJ, Mottram JC, Coombs GH, Parasitology 2000 121 367 377 10.1017/S0031182099006435 11072899
50. Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana. Bart G, Frame MJ, Carter R, Coombs GH, Mottram JC, Mol Biochem Parasitol 1997 88 1-2 53 61 9274867 (Pubitemid 27346817)
51. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Mottram JC, Brooks DR, Coombs GH, Curr Opin Microbiol 1998 1 4 455 460 10.1016/S1369-5274(98)80065-9 10066510 (Pubitemid 128423262)
52. Functional analysis of cathepsin B-like cysteine proteases fromLeishmania donovanicomplex. Evidence for the activation of latent transforming growth factor beta. Somanna A, Mundodi V, Gedamu L, J Biol Chem 2002 277 28 25305 25312 10.1074/jbc.M203034200 12000761 (Pubitemid 34951840)
53. The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function. Yao C, Donelson JE, Wilson ME, Mol Biochem Parasitol 2003 132 1 1 16 10.1016/S0166-6851(03)00211-1 14563532 (Pubitemid 37239002)
54. Major Surface Protease of Trypanosomatids: One Size Fits All? Yao C, Infect Immun 2010 78 1 22 31 10.1128/IAI.00776-09 19858295
55. Down-regulation of gp63 level in Leishmania amazonensis promastigotes reduces their infectivity in BALB/c mice. Thiakaki M, Kolli B, Chang KP, Soteriadou K, Microbes Infect 2006 8 6 1455 1463 10.1016/j.micinf.2006.01.006 16698300 (Pubitemid 43903315)
56. A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression. Gregory DJ, Godbout M, Contreras I, Forget G, Olivier M, Eur J Immunol 2008 38 4 1071 1081 10.1002/eji.200737586 18383035
57. Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Lieke T, Nylén S, Eidsmo L, McMaster WR, Mohammadi AM, Khamesipour A, Berg L, Akuffo H, Clin Exp Immunol 2008 153 2 221 230 10.1111/j.1365-2249.2008.03687.x 18713141 (Pubitemid 351989161)
58. The major surface glycoprotein (gp63) from Leishmania major and Leishmania donovani cleaves CD4 molecules on human T cells. Hey AS, Theander TG, Hviid L, Hazrati SM, Kemp M, Kharazmi A, J Immunol 1994 152 9 4542 4548 7908919 (Pubitemid 24134412)
59. Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. Contreras I, Gámez MA, Nguyen O, Shio MT, McMaster RW, Olivier M, PLoS Pathog 2010 6 1 1001148 10.1371/journal.ppat.1001148 20976196
60. The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion. Swenerton RK, Zhang S, Sajid M, Medzihradszky KF, Craik CS, Kelly BL, McKerrow JH, J Biol Chem 2011 286 1 429 440 10.1074/jbc.M110.138313 20961853
61. Leishmania subtilisin is a maturase for the trypanothione reductase system and contributes to disease pathology. Swenerton RK, Knudsen GM, Sajid M, Kelly BL, McKerrow JH, J Biol Chem 2010 285 41 31120 31129 10.1074/jbc.M110. 114462 20675366
62. TGF-beta-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens. Pinheiro RO, Pinto EF, Lopes JR, Guedes HL, Fentanes RF, Rossi-Bergmann B, Microbes Infect 2005 7 13 1317 1323 10.1016/j.micinf.2005.04.016 16027022 (Pubitemid 41572309)
63. MEROPS: the peptidase database. Rawlings ND, Barrett AJ, Bateman A, Nucleic Acids Res 2010 38 227 D233 10.1093/nar/gkp971 19892822
64. Subcellular localization of an extracellular serine protease in Leishmania (Leishmania) amazonensis. Silva-Lopez RE, Morgado-Díaz JA, Alves CR, Côrte-Real S, Giovanni-De-Simone S, Parasitol Res 2004 93 4 328 331 15185145 (Pubitemid 39044235)
65. Leishmania amazonensis: early proteinase activities during promastigote-amastigote differentiation in vitro. Alves CR, Corte-Real S, Bourguignon SC, Chaves CS, Saraiva EM, Exp Parasitol 2005 109 1 38 48 10.1016/j.exppara.2004.10.005 15639138 (Pubitemid 40089511)
66. Leishmania mexicana: identification and characterization of an aspartyl proteinase activity. Valdivieso E, Dagger F, Rascán A, Exp Parasitol 2007 116 1 77 82 10.1016/j.exppara.2006.10.006 17126324 (Pubitemid 46412309)
67. Cysteine proteases of parasitic organisms. Sajid M, McKerrow JH, Mol Biochem Parasitol 2002 120 1 1 21 10.1016/S0166-6851(01)00438-8 11849701 (Pubitemid 34159288)
68. Proteases in parasitic diseases. McKerrow JH, Caffrey C, Kelly B, Loke P, Sajid M, Ann Rev Pathol 2006 1 497 536 10.1146/annurev.pathol.1.110304.100151
69. Cysteine protease inhibitors as chemotherapy: lessons from a parasite targe. Selzer PM, Pingel S, Hsieh I, Ugele B, Chan VJ, Engel JC, Bogyo M, Russell DG, Sakanari JA, McKerrow JH, Proc Natl Acad Sci USA 1999 96 20 11015 11022 10.1073/pnas.96.20.11015 10500116 (Pubitemid 29487320)
70. Biological Roles of Peptidases in Trypanosomatids. Vermelho AB, Branquinha MH, DÁvila-Levy CM, Santos ALS, Dias EPS, Melo ACN, Open Parasitol J 2010 4 5 23 10.2174/1874421401004010005
71. Leishmania major: comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids. Sakanari JA, Nadler SA, Chan VJ, Engel JC, Leptak C, Bouvier J, Exp Parasitol 1997 85 1 63 76 10.1006/expr.1996.4116 9024203 (Pubitemid 27236715)
72. Cathepsin B-like cysteine proteases of Leishmania mexicana. Robertson CD, Coombs GH, Mol Biochem Parasitol 1993 62 2 271 279 10.1016/0166-6851(93)90116-F 8139620
73. Multiple high activity cysteine proteases of Leishmania mexicana are encoded by the Imcpb gene array. Robertson CD, Coombs GH, Microbiology 1994 140 2 417 424 10.1099/13500872-140-2-417 8180705 (Pubitemid 24090609)
74. Characterization of a multi-copy gene for a major stage-specific cysteine proteinase of Leishmania mexicana. Souza AE, Waugh S, Coombs GH, Mottram JC, FEBS Lett 1992 311 2 124 127 10.1016/0014-5793(92)81382-V 1397299
75. The multiple cpb cysteine proteinase genes of Leishmania mexicana encode isoenzymes that differ in their stage regulation and substrate preferences. Mottram JC, Frame MJ, Brooks DR, Tetley L, Hutchison JE, Souza AE, Coombs GH, J Biol Chem 1997 272 22 14285 14293 10.1074/jbc.272.22.14285 9162063 (Pubitemid 27232842)
76. Identification of two distinct cysteine proteinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction. Traub-Cseko YM, Duboise M, Boukai LK, McMahon-Pratt D, Mol Biochem Parasitol 1993 57 1 101 115 10.1016/0166-6851(93)90248-V 8426606
77. Cloning and characterization of a cysteine proteinase gene expressed in amastigotes of Leishmania (L.) amazonensis. Lasakosvitsch F, Gentil LG, dos Santos MR, da Silveira JF, Barbiéri CL, Int J Parasitol 2003 33 4 445 454 10.1016/S0020-7519(03)00010-9 12705937 (Pubitemid 36423244)
78. Genomic organization and functional expression of differentially regulated cysteine protease genes of Leishmania donovani complex. Mundodi V, Somanna A, Farrell PJ, Gedamu L, Gene 2002 282 1-2 257 265 11814698 (Pubitemid 34117582)
79. Polymorphisms of cpb multicopy genes in the Leishmania (Leishmania) donovani complex. Hide M, Bãuls AL, Trans R Soc Trop Med Hyg 2008 102 2 105 106 10.1016/j.trstmh.2007.09.013 17996911
80. Leishmania (Leishmania) amazonensis: differential expression of proteinases and cell-surface polypeptides in avirulent and virulent promastigotes. de Araújo Soares RM, dos Santos AL, Bonaldo MC, de Andrade AF, Alviano CS, Angluster J, Goldenberg S, Exp Parasitol 2003 104 3-4 104 112 14552857 (Pubitemid 37211298)
81. Virulence and protective potential of several Cysteine peptidase knockout strains of Leishmania infantum in hamsters. Poot J, Denise H, Herrmann DC, Mottram JC, Coombs GH, Vermeulen AN, Experimental challenge models for canine leishmaniasis in hamsters and dogs, optimization and application in vaccine research Utrecht University press, Utrecht, Netherlands, Poot J, 2006 93 107
82. Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibition. Mundodi V, Kucknoor AS, Gedamu L, BMC Mol Biol 2005 6 1 3 10.1186/1471-2199-6-3 15691375 (Pubitemid 41418211)
83. Leishmania tropica: cysteine proteases are essential for growth and pathogenicity. Mahmoudzadeh-Niknam H, McKerrow JH, Exp Parasitol 2004 106 3-4 158 163 15172223 (Pubitemid 38686285)
84. Cysteine proteinases from promastigotes of Leishmania (Viannia) braziliensis. Rebello KM, Côrtes LM, Pereira BA, Pascarelli BM, Côrte-Real S, Finkelstein LC, Pinho RT, d'Avila-Levy CM, Alves CR, Parasitol Res 2009 106 1 95 104 10.1007/s00436-009-1632-5 19777260
85. Expression and substrate specificity of a recombinant cysteine proteinase B of Leishmania braziliensis. Lanfranco MF, Loayza-Muro R, Clark D, Nú̃ez R, Zavaleta AI, Jimenez M, Meldal M, Coombs GH, Mottram JC, Izidoro M, Juliano MA, Juliano L, Arévalo J, Mol Biochem Parasitol 2008 161 2 91 100 10.1016/j.molbiopara.2008.06.005 18639590
86. The biosynthesis, processing, and immunolocalization of Leishmania pifanoi amastigote cysteine proteinases. Duboise SM, Vannier-Santos MA, Costa-Pinto D, Rivas L, Pan AA, Traub-Cseko Y, De Souza W, McMahon-Pratt D, Mol Biochem Parasitol 1994 68 1 119 132 10.1016/0166-6851(94)00157-X 7891736 (Pubitemid 24358622)
87. Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models. Saravia NG, Escorcia B, Osorio Y, Valderrama L, Brooks D, Arteaga L, Coombs G, Mottram J, Travi BL, Vaccine 2006 24 19 4247 4259 10.1016/j.vaccine.2005.05.045 16216395
88. Cysteine peptidases CPA and CPB are vital for autophagy and differentiation in Leishmania mexicana. Williams RA, Tetley L, Mottram JC, Coombs GH, Mol Microbiol 2006 61 3 655 674 10.1111/j.1365-2958.2006.05274.x 16803590 (Pubitemid 44324091)
89. Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes. Bouvier J, Etges RJ, Bordier C, J Biol Chem 1985 260 29 15504 15509 4066680 (Pubitemid 16170085)
90. Evidence that the major surface proteins of three Leishmania species are structurally related. Etges RJ, Bouvier J, Hoffman R, Bordier C, Mol Biochem Parasitol 1985 14 2 141 149 10.1016/0166-6851(85)90033-7 3990704 (Pubitemid 15174625)
91. The major surface protein of Leishmania promastigotes is a protease. Etges R, Bouvier J, Bordier C, J Biol Chem 1986 261 20 9098 9101 3522584 (Pubitemid 17218176)
92. The crystal structure of the Leishmania major surface proteinase leishmanolysin (gp63). Schlagenhauf E, Etges R, Metcalf P, Structure 1998 6 8 1035 1046 10.1016/S0969-2126(98)00104-X 9739094 (Pubitemid 28397924)
93. Cellular localization and expression of gp63 homologous metalloproteases in Leishmania (Viannia) braziliensis strains. Cuervo P, Santos AL, Alves CR, Menezes GC, Silva BA, Britto C, Fernandes O, Cupolillo E, Batista De Jesus J, Acta Trop 2008 106 3 143 148 10.1016/j.actatropica.2008.03.005 18423419
94. Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Gomez MA, Contreras I, Hallé M, Tremblay ML, McMaster RW, Olivier M, Sci Signal 2009 2 90 a58 10.1126/scisignal.2000213 19797268
95. In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate. Choudhury R, Das P, Bhaumik SK, De T, Chakraborti T, Clin Vaccine Immunol 2010 17 4 660 667 10.1128/CVI.00358-09 20106998
96. Oligopeptidase B deficient mutants of Leishmania major. Munday JC, McLuskey K, Brown E, Coombs GH, Mottram JC, Mol Biochem Parasitol 2011 175 1 49 57 10.1016/j.molbiopara.2010.09.003 20883728
97. Matrix metalloproteinase-9 delays wound healing in a murine wound model. Reiss MJ, Han YP, Garcia E, Goldberg M, Yu H, Garner WL, Surgery 2010 147 2 295 302 10.1016/j.surg.2009.10.016 20004432
98. Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression. Maretti-Mira AC, de Oliveira-Neto MP, Da-Cruz AM, de Oliveira MP, Craft N, Pirmez C, Clin Exp Immunol 2011 163 2 207 214 10.1111/j.1365-2249.2010.04285.x 21091666
99. In vitro evidence for metallopeptidase participation in hepatocyte damage induced by Leishmania chagasi-infected macrophages. Costa JD, de Melo AC N, Vermelho AB, Meirelles Mde N, Porrozzi R, Acta Trop 2008 106 3 175 183 10.1016/j.actatropica.2008.03.006 18433728
100. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Agren MS, Mirastschijski U, Karlsmark T, Saarialho-Kere UK, Exp Dermatol 2001 10 5 337 348 10.1034/j.1600-0625.2001. 100506.x 11589731 (Pubitemid 32916283)
101. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. Stearns ME, Wang M, Hu Y, Garcia FU, Rhim J, Clin Cancer Res 2003 9 3 1191 1199 12631625 (Pubitemid 36323729)